相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
E. Ayuso et al.
GENE THERAPY (2010)
Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene Therapy
Gregory D. Hurlbut et al.
MOLECULAR THERAPY (2010)
Scalable Purification of Adeno-Associated Virus Serotype 1 (AAV1) and AAV8 Vectors, Using Dual Ion-Exchange Adsorptive Membranes
Takashi Okada et al.
HUMAN GENE THERAPY (2009)
Producing Recombinant Adeno-Associated Virus in Foster Cells: Overcoming Production Limitations Using a Baculovirus-Insect Cell Expression Strategy
Tamas Virag et al.
HUMAN GENE THERAPY (2009)
Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical Studies
Nathalie Clement et al.
HUMAN GENE THERAPY (2009)
African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension
M. Khaleghi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Undetectable Transcription of cap in a Clinical AAV Vector: Implications for Preformed Capsid in Immune Responses
Bernd Hauck et al.
MOLECULAR THERAPY (2009)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
Amit C. Nathwani et al.
BLOOD (2007)
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Luk H. Vandenberghe et al.
NATURE MEDICINE (2006)
Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver
AC Nathwani et al.
BLOOD (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery
G Chadeuf et al.
MOLECULAR THERAPY (2005)
Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models
AM Davidoff et al.
MOLECULAR THERAPY (2005)
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors
CE Thomas et al.
JOURNAL OF VIROLOGY (2004)
Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock
AM Davidoff et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno et al.
BLOOD (2003)
Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo
Z Wang et al.
GENE THERAPY (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo
DM McCarty et al.
GENE THERAPY (2003)
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
JM Sommer et al.
MOLECULAR THERAPY (2003)
A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and-5
N Brument et al.
MOLECULAR THERAPY (2002)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques
AC Nathwani et al.
BLOOD (2002)
Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography
N Kaludov et al.
HUMAN GENE THERAPY (2002)
Gene therapy of Canavan disease:: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain
C Janson et al.
HUMAN GENE THERAPY (2002)
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
JD Mount et al.
BLOOD (2002)
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity
JE Rabinowitz et al.
JOURNAL OF VIROLOGY (2002)
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo
H Nakai et al.
JOURNAL OF VIROLOGY (2001)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis
DM McCarty et al.
GENE THERAPY (2001)
Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA
AC Nathwani et al.
BLOOD (2001)
Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy
RR Ali et al.
NATURE GENETICS (2000)
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
DS Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
LL Wang et al.
MOLECULAR THERAPY (2000)
Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
CL Halbert et al.
JOURNAL OF VIROLOGY (2000)
分享论文
